Farmaforum 2024

26 Sept 2024 | Madrid, Spain

ProductUpdated on 19 September 2024

Lisdexamfetamine dimesylate active pharmaceutical ingredient

Jose Alonso

CEO at Skalar Pharma LLC

Guaynabo, Puerto Rico

About

Lisdexamfetamine dimesylate (Vyvanse) is in short supply in the U.S. and other locations. This product is utilized for ADHD and Binge Eating Disorder. We have all state and DEA licenses for a Schedule II controlled substance. Our product meets the highest standards of quality and safety.

Similar opportunities